Stockscreener 앱 받기
0.3975
7.37%
0.0273
Generation Bio Co 주식(GBIO)의 최신 뉴스
Generation Bio stock hits 52-week low at $0.4 amid steep decline - Investing.com Australia
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference - The Manila Times
Generation Bio Takes Center Stage: CEO Fireside Chat at Major Healthcare Conference - Stock Titan
Charles Schwab Investment Management Inc. Cuts Stake in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace
Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates - MSN
Generation Bio stock hits 52-week low at $0.47 By Investing.com - Investing.com South Africa
Generation Bio stock hits 52-week low at $0.47 - Investing.com
Generation Bio’s (GBIO) Buy Rating Reaffirmed at Canaccord Genuity Group - Defense World
Generation Bio’s SWOT analysis: stock pivots to T-cell focus amid market caution By Investing.com - Investing.com South Africa
Generation Bio’s SWOT analysis: stock pivots to T-cell focus amid market caution - Investing.com Australia
Generation Bio’s (GBIO) Outperform Rating Reiterated at Wedbush - Defense World
Generation Bio Co. (NASDAQ:GBIO) Not Doing Enough For Some Investors As Its Shares Slump 29% - Simply Wall St
Generation Bio Co. Advances in Autoimmune Therapeutics - TipRanks
Generation Bio Co reports results for the quarter ended December 31Earnings Summary - TradingView
Generation Bio stock holds Market Perform rating at JMP - Investing.com India
Generation Bio stock holds Market Perform rating at JMP By Investing.com - Investing.com UK
Generation Bio earnings missed by $0.02, revenue topped estimates - Investing.com South Africa
Generation Bio Co (GBIO) Q4 2024 Earnings: EPS Misses Estimate o - GuruFocus.com
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Generation Bio Co. Advances T Cell-Selective siRNA Therapeutics for Autoimmune Diseases, Announces Robust Financial Position - Nasdaq
Generation Bio's Breakthrough: 98% T Cell Success Powers $185M Cash Runway Through 2027 - StockTitan
Generation Bio Co (GBIO)’s stock rises to 0.52 per share - US Post News
Generation Bio stock hits 52-week low at $0.52 By Investing.com - Investing.com Australia
A Guide To The Risks Of Investing In Generation Bio Co (GBIO) - Knox Daily
Generation Bio stock hits 52-week low at $0.52 - Investing.com
Generation Bio (GBIO) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Contrasting Generation Bio (NASDAQ:GBIO) & Anthera Pharmaceuticals (OTCMKTS:ANTH) - Defense World
Generation Bio faces Nasdaq delisting over share price By Investing.com - Investing.com Canada
Generation Bio faces Nasdaq delisting over share price - Investing.com India
Generation Bio to Present at the TD Cowen 45th Annual Health Care Conference - The Manila Times
Can Generation Bio's Autoimmune Disease Strategy Transform T Cell Treatment? CEO Reveals Plans - StockTitan
Kineticos Launches Kinvard Bio to Advance Next-Generation Antibiotics in the Fight Against Antimicrobial Resistance - PR Newswire
Generation Bio stock hits 52-week low at $0.6 amid sharp decline - Investing.com Nigeria
Generation Bio stock hits 52-week low at $0.6 amid sharp decline By Investing.com - Investing.com South Africa
Spore.Bio raises €22 million to deploy a new generation of AI-based microbiology testing - EU-Startups
1.23%
1.63%
자본화:
|
볼륨(24시간):